†Both authors contributed equally.
Bcl-2 Inhibition to Overcome Memory Cell Barriers in Transplantation
Version of Record online: 28 JAN 2014
© Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 14, Issue 2, pages 333–342, February 2014
How to Cite
Cippà, P. E., Gabriel, S. S., Kraus, A. K., Chen, J., Wekerle, T., Guimezanes, A., Wüthrich, R. P. and Fehr, T. (2014), Bcl-2 Inhibition to Overcome Memory Cell Barriers in Transplantation. American Journal of Transplantation, 14: 333–342. doi: 10.1111/ajt.12554
- Issue online: 28 JAN 2014
- Version of Record online: 28 JAN 2014
- Manuscript Accepted: 17 OCT 2013
- Manuscript Revised: 14 OCT 2013
- Manuscript Received: 6 DEC 2012
- Swiss National Science Foundation. Grant Numbers: 323530-133893, 310000-121979
- Zurich Center of Integrative Human Physiology (ZIHP)
- Olga Mayenfisch Stiftung
Additional Supporting Information may be found in the online version of this article.
|ajt12554-sm-0001-SuppFig-S1.pdf||47K||Figure S1: In vivo generated Tm are sensitive to ABT-737. (A, B) To assess the sensitivity of in vivo generated Tm to ABT-737, CBA mice were primed with B6 splenocytes. Eight weeks after priming, sensitivity to ABT-737 was determined by measuring cell viability after 12 h incubation with ABT-737. Sensitivity to ABT-737-induced apoptosis of naïve (CD44−) and memory (CD44+) CD4 and CD8 T cells is shown. CI, confidence interval; IC50, half maximal inhibitory concentration.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.